Why the Nuheara (ASX:NUH) share price is up today

The Nuheara Ltd (ASX: NUH) share price opened 13% higher today after the company announced FDA approval for one of its flagship products.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Nuheara Ltd (ASX: NUH) share price opened 13% up today after the smart hearing technology company announced its IQbuds2 PRO (PRO) product has received US FDA registration.

The PRO is a hearing aid designed to provide high levels of hearing enhancement and amplification with up-to-date hearing technology.

The Nuheara share price has dropped since this morning but remains more than 2% higher than yesterday's close.

More about Nuheara's hearing aids

The PRO is the second product delivered from Nuheara's IQbuds2 hardware platform. It is designed for those with moderate hearing challenges.

It's expected to be launched in the US later this year, extending the company's reach in the global US$9 billion per annum hearing aid market. The North American market alone is worth US$3.37 billion.

Nuheara advised that, as with all hearing aids with air conductions and wireless technology, the PRO is exempt from clinical trials. This means the product can go straight to market in the US.

IQbuds2 MAX (MAX) was the first product to be developed from Nuheara's hardware platform. MAX is designed to meet the needs of those with mild hearing challenges.

Commentary from management

CEO of Nuheara Justin Miller said the development of the PRO and MAX are significant in making hearing health more accessible and affordable.

Over many years the business has invested tens of millions of dollars in our proprietary hearing technology platform. The IQbuds² PRO as a hearing aid device represents further opportunities to expand Nuheara's leadership position in both hardware and software of hearing health devices. This registration effectively enables Nuheara to meet the varied hearing needs of a growing base of underserved customers with a wider spectrum of hearing loss.

Nuheara share price snapshot

The Nuheara share price is currently at 4.5 cents, up 2.27% from yesterday's close. It is down 8% year to date but up 95% over the last 12 months.

Nuheara has a market capitalisation of $75.8 million and approximately 1.7 billion shares outstanding.

Motley Fool contributor Brooke Cooper has no position in any of the shares mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ASX Share Market News

Sad man sitting at desk and grabbing his head as he looks at a laptop.
ASX Share Market News

5 things to watch on the ASX 200 on Friday

It looks set to be a poor finish to the week for Aussie investors.

Read more »

Farmer holding grains in his hands.
Broker Notes

Why this broker thinks GrainCorp shares are a buy after yesterday's fall

This broker is expecting a rebound.

Read more »

A young man holds a small bottle of beer as he slumps sadly on one elbow in a comfortable chair with his head propped in his hand and staring into space with a dejected look on his face.
Share Gainers

Here are the top 10 ASX 200 shares today

It was not a pleasant day on the ASX...

Read more »

Doctor with stethoscope holding a tablet and smiling.
Healthcare Shares

ASX healthcare shares are 39% higher since June. Are you missing out?

Healthcare stocks endured a long slump before the sector pivoted three months ago.

Read more »

A man holds his hand to his chin with a furrowed brow, making an expression of puzzlement or confusion.
Share Fallers

Top 3 ASX 200 shares now below their 200-day moving average

Are these businesses still a buy?

Read more »

Six smiling office colleagues stand in a row and look at the camera.
Broker Notes

9 ASX 200 shares earning strengthened buy ratings this week

Brokers retained a positive view on Santos, Goodman, AMP, Telstra, and other shares this week. 

Read more »

Three scientists wearing white coats and blue gloves dance together in a lab.
ASX Share Market News

CSL shares are up 90%. Brokers can't agree what happens next

A $75 gap between the bulls and the bears.

Read more »

Happy work colleagues give each other a fist pump.
Opinions

Megaport shares have surged 10% in a week to $18. I think they could hit $25

This tech stock could have plenty more upside from here.

Read more »